NDC 71288-129

Dactinomycin

Dactinomycin

Dactinomycin is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Meitheal Pharmaceuticals Inc.. The primary component is Dactinomycin.

Product ID71288-129_d9bb02eb-3f9e-4932-bdcd-53b5bd6392b6
NDC71288-129
Product TypeHuman Prescription Drug
Proprietary NameDactinomycin
Generic NameDactinomycin
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2020-11-13
Marketing CategoryANDA / ANDA
Application NumberANDA213463
Labeler NameMeitheal Pharmaceuticals Inc.
Substance NameDACTINOMYCIN
Active Ingredient Strength1 mg/mL
Pharm ClassesActinomycin [EPC],Nucleic Acid Synthesis Inhibitors [MoA],Protein Synthesis Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 71288-129-02

1 VIAL, SINGLE-DOSE in 1 CARTON (71288-129-02) > 1 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2020-11-13
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Dactinomycin" or generic name "Dactinomycin"

NDCBrand NameGeneric Name
39822-2100dactinomycindactinomycin
42658-008Dactinomycindactinomycin
55150-431DACTINOMYCINDACTINOMYCIN
55150-928DACTINOMYCINDACTINOMYCIN
66993-489DactinomycinDactinomycin
67457-513DactinomycinDactinomycin
67457-928DactinomycinDactinomycin
71288-129DactinomycinDactinomycin
55292-811Cosmegendactinomycin

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.